Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

FDA Warns Against Compounded Drugs in BD Syringes

Wednesday, August 19, 2015   (0 Comments)
Posted by: Dagmar Anderson
Share |


The Food & Drug Administration (FDA) is alerting health care professionals not to administer to patients compounded or repackaged drugs that have been stored in 3 milliliter (ml) and 5ml syringes manufactured by Becton-Dickinson (BD) unless there is no suitable alternative available. Preliminary information indicates that drugs stored in these syringes may lose potency over a period of time due to a possible interaction with the rubber stopper in the syringe. 


Please click here to read more.

Association Management Software Powered by®  ::  Legal